Adjuvant EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: still an investigational approach.

ABSTRACT:

SUBMITTER: Jassem J 

PROVIDER: S-EPMC6987370 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature